Castagna A - Search Results

1

Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients.

Gianotti N, Poli A, Nozza S, Galli L, Galizzi N, Ripa M, Merli M, Carbone A, Spagnuolo V, Lazzarin A, Castagna A. Gianotti N, et al. Among authors: castagna a. BMC Infect Dis. 2017 Nov 16;17(1):723. doi: 10.1186/s12879-017-2831-9. BMC Infect Dis. 2017. PMID: 29145807 Free PMC article.

2

Virological response to salvage therapy in HIV-infected persons carrying the reverse transcriptase K65R mutation.

Antinori A, Trotta MP, Lorenzini P, Torti C, Gianotti N, Maggiolo F, Ceccherini-Silberstein F, Nasto P, Castagna A, De Luca A, Mussini C, Andreoni M, Perno CF; GNOMO Study Group. Antinori A, et al. Among authors: castagna a. Antivir Ther. 2007;12(8):1175-83. Antivir Ther. 2007. PMID: 18240858

3

Patients presenting with AIDS in the HAART era: a collaborative cohort analysis.

Mussini C, Manzardo C, Johnson M, Monforte Ad, Uberti-Foppa C, Antinori A, Gill MJ, Sighinolfi L, Borghi V, Lazzarin A, Miró JM, Sabin C; Late Presenter Investigators. Mussini C, et al. AIDS. 2008 Nov 30;22(18):2461-9. doi: 10.1097/QAD.0b013e328314b5f1. AIDS. 2008. PMID: 19005269

4

Changes in darunavir/r resistance score after previous failure to tipranavir/r in HIV-1-infected multidrug-resistant patients.

Spagnuolo V, Gianotti N, Seminari E, Galli L, Fusetti G, Salpietro S, Lazzarin A, Castagna A. Spagnuolo V, et al. Among authors: castagna a. J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):192-5. doi: 10.1097/QAI.0b013e31819367fc. J Acquir Immune Defic Syndr. 2009. PMID: 19131889

5

Dynamic patterns of human immunodeficiency virus type 1 integrase gene evolution in patients failing raltegravir-based salvage therapies.

Canducci F, Sampaolo M, Marinozzi MC, Boeri E, Spagnuolo V, Galli A, Castagna A, Lazzarin A, Clementi M, Gianotti N. Canducci F, et al. Among authors: castagna a. AIDS. 2009 Feb 20;23(4):455-60. doi: 10.1097/QAD.0b013e328323da60. AIDS. 2009. PMID: 19165083

6

Survival of HIV-1 infected multidrug-resistant patients recycling enfuvirtide after a previous failure.

Cossarini F, Galli L, Sagnelli C, Gianotti N, Hasson H, Clementi M, Soria A, Salpietro S, Lazzarin A, Castagna A. Cossarini F, et al. Among authors: castagna a. J Acquir Immune Defic Syndr. 2009 Jun 1;51(2):179-84. doi: 10.1097/QAI.0b013e3181a56f46. J Acquir Immune Defic Syndr. 2009. PMID: 19352200

7

Protease inhibitor resistance analysis in the MONARK trial comparing first-line lopinavir-ritonavir monotherapy to lopinavir-ritonavir plus zidovudine and lamivudine triple therapy.

Delaugerre C, Flandre P, Chaix ML, Ghosn J, Raffi F, Dellamonica P, Jaeger H, Shürmann D, Cohen-Codar I, Van PN, Norton M, Taburet AM, Delfraissy JF, Rouzioux C; MONARK Study Group. Delaugerre C, et al. Antimicrob Agents Chemother. 2009 Jul;53(7):2934-9. doi: 10.1128/AAC.01643-08. Epub 2009 May 18. Antimicrob Agents Chemother. 2009. PMID: 19451297 Free PMC article. Clinical Trial.

8

Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients.

Morsica G, Bagaglio S, Cicconi P, Capobianchi MR, Pellizzer G, Caramello P, Orani A, Moioli C, Rizzardini G, Uberti-Foppa C, Puoti M, Monforte AD; Hepa I.C.o.N.A the Icona Foundation Study Groups. Morsica G, et al. J Acquir Immune Defic Syndr. 2009 Aug 15;51(5):574-81. doi: 10.1097/QAI.0b013e3181add592. J Acquir Immune Defic Syndr. 2009. PMID: 19590432

9

Magnitude and determinants of CD4 recovery after HAART resumption after 1 cycle of treatment interruption.

Mussini C, Touloumi G, Bakoyannis G, Sabin C, Castagna A, Sighinolfi L, Erikson LE, Bratt G, Borghi V, Lazzarin A, Cossarizza A, Esposito R. Mussini C, et al. Among authors: castagna a. J Acquir Immune Defic Syndr. 2009 Dec;52(5):588-94. doi: 10.1097/qai.0b013e3181b9e94d. J Acquir Immune Defic Syndr. 2009. PMID: 19950432

10

Viro-immunological dynamics in HIV-1-infected subjects receiving once-a-week emtricitabine to delay treatment change after failure: a pilot randomised trial.

Soria A, Danise A, Galli L, Tiberi S, Seminari E, Cossarini F, Bigoloni A, Marcotullio S, Lazzarin A, Castagna A. Soria A, et al. Among authors: castagna a. J Clin Virol. 2010 Mar;47(3):253-7. doi: 10.1016/j.jcv.2009.12.007. Epub 2010 Jan 6. J Clin Virol. 2010. PMID: 20056480 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,083 results

Search Page